NYSE - Nasdaq Real Time Price USD

Haleon plc (HLN)

Compare
10.50 +0.11 (+1.06%)
At close: September 10 at 4:00 PM EDT
10.51 +0.01 (+0.08%)
After hours: September 10 at 7:31 PM EDT
Loading Chart for HLN
DELL
  • Previous Close 10.39
  • Open 10.43
  • Bid 10.39 x 4000
  • Ask 10.51 x 21500
  • Day's Range 10.42 - 10.50
  • 52 Week Range 7.70 - 10.50
  • Volume 3,197,688
  • Avg. Volume 3,875,640
  • Market Cap (intraday) 47.835B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 33.87
  • EPS (TTM) 0.31
  • Earnings Date Aug 1, 2024
  • Forward Dividend & Yield 0.16 (1.52%)
  • Ex-Dividend Date Aug 16, 2024
  • 1y Target Est 10.49

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

www.haleon.com

25,408

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HLN

View More

Performance Overview: HLN

Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

HLN
29.85%
FTSE 100
6.11%

1-Year Return

HLN
34.26%
FTSE 100
9.73%

3-Year Return

HLN
41.70%
FTSE 100
12.31%

5-Year Return

HLN
41.70%
FTSE 100
12.31%

Compare To: HLN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HLN

View More

Valuation Measures

Annual
As of 9/9/2024
  • Market Cap

    47.02B

  • Enterprise Value

    57.95B

  • Trailing P/E

    33.53

  • Forward P/E

    19.42

  • PEG Ratio (5yr expected)

    1.48

  • Price/Sales (ttm)

    3.24

  • Price/Book (mrq)

    2.17

  • Enterprise Value/Revenue

    3.92

  • Enterprise Value/EBITDA

    18.68

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.66%

  • Return on Assets (ttm)

    4.45%

  • Return on Equity (ttm)

    6.82%

  • Revenue (ttm)

    11.26B

  • Net Income Avi to Common (ttm)

    1.09B

  • Diluted EPS (ttm)

    0.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    531M

  • Total Debt/Equity (mrq)

    54.18%

  • Levered Free Cash Flow (ttm)

    1.68B

Research Analysis: HLN

View More

Company Insights: HLN

Research Reports: HLN

View More

People Also Watch